Patient P-02313

Synthetic patientMETA-24 · Day 139 · 35–44 · M · baseline S02Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

24%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S02
Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 89 CR-01 recommended — Clinician Review CR-01
Day 90 Patient declined — Not now

What changed?

Trajectory began diverging from predicted response on Day 10.

Primary contributors, last 14 days

Toxicity+20
Inflammatory activity+17
Nutritional resilience-10
GI instability+4
Treatment adherence+3

What helped?

Clinician Review CR-01Day 89
Declined by patient

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

80 min

stable · +0.5 vs previous 14 d

Sleep duration

Wearable

6.9 h

stable · -0.2 vs previous 14 d

Energy level

Daily log

5.3/10

worsening · -1.2 vs previous 14 d

Steps

Wearable

9,748

stable · -25 vs previous 14 d

GI burden

Companion

20.5/100

worsening · +7.7 vs previous 14 d

Adherence

Companion

93.2 %

stable · -0.6 vs previous 14 d

Sleep quality

Wearable

52.4/100

worsening · -6.7 vs previous 14 d

Glucose, CGM daily mean

CGM

129 mg/dL

stable · +4.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 67 from the failing basin, 25 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -5.9 next day on high-intake days · n 20

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-5.9supporter · 95%
Ultra-processed food
+2.4no signal · 45%
Dietary fat load
+2no signal · 37%
Insoluble fibre
+2no signal · 40%
Caffeine
+1.7no signal · 32%
Histamine load
-0.3no signal · 15%
Simple carbohydrates
+0.3no signal · 15%
Alcohol
+0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 3.2 · butyrate capacity 66/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 62 ms
Sleep: 7.7 h
Steps: 8,963
Resting HR: 71 bpm

Daily log: GI score 21, nutritional resilience 58, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02082	45%	S12	NP-02	improved	53
P-02685	43%	S16	DT-01	improved	47
P-02462	42%	S12	DT-01	improved	65
P-02697	42%	S07	GI-04	improved	56
P-02235	40%	S14	DT-01	improved	50
P-02645	40%	S02	HY-01	improved	56
P-02274	39%	S15	DT-01	improved	50
P-02303	39%	S15	GI-04	improved	48
P-02218	38%	S01	DT-01	improved	61
P-02339	38%	S03	DT-01	improved	50
P-02441	38%	S11	SC-12	improved	67
P-02484	38%	S15	GI-04	improved	49